thorinane
pharmathen s.a. - enoksaparin natrij - venska tromboembolija - antitrombotična sredstva - thorinane je primerna za odrasle za: - za preventivo venske thromboembolism, še posebej pri bolnikih, ki opravljajo ortopedske, splošne ali onkoloških operacijo. - za preventivo venske thromboembolism pri bolnikih, vezan na posteljo zaradi akutne bolezni, vključno z akutno srčno popuščanje, akutna dihalna odpoved, hude okužbe, kot tudi akutne revmatske bolezni, ki povzročajo imobilizacijo bolnika (velja za prednosti 40 mg/0. 4 ml). - zdravljenje globoke venske tromboze (dvt), zapletena ali pa enostavno za pljučna embolija. - zdravljenje nestabilne angine in ne q val miokardni infarkt, v kombinaciji z acetilsalicilne kisline (asa). - zdravljenje akutne st segmentu višinskih miokardni infarkt (stemi), vključno z bolniki, ki bodo zdravljeni konzervativno ali ki se bo kasneje prihajalo perkutani koronarni angioplastiko (velja za prednosti 60 mg/0. 6 ml, 80 mg/0. 8 ml in 100 mg/1 ml). - krvni strdek preprečevanje extracorporeal obtoku med hemodializo. preprečevanje in zdravljenje različnih bolezni, povezanih s krvnih strdkov pri odraslih.
docetaksel strides arcolab international 40 mg/ml koncentrat in vehikel za raztopino za raztopino za infundiranje
strides arcolab international limited - docetaksel - koncentrat in vehikel za raztopino za infundiranje - docetaksel 40 mg / 1 ml - docetaksel
docetaksel strides arcolab international 40 mg/ml koncentrat in vehikel za raztopino za raztopino za infundiranje
strides arcolab international limited - docetaksel - koncentrat in vehikel za raztopino za infundiranje - docetaksel 40 mg / 1 ml - docetaksel
enhertu
daiichi sankyo europe gmbh - trastuzumab deruxtecan - neoplazme dojke - antineoplastična sredstva - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.
ambroksolijev klorid berlin-chemie 6 mg/ml peroralna raztopina
berlin-chemie ag - ambroksol - peroralna raztopina - ambroksol 5,47 mg / 1 ml - ambroksol
interflox
interchemie werken de adelaar eesti as vanapere tee 14 -
calmafusion
interchemie werken de adelaar eesti as vanapere tee 14 -
sedachem
interchemie werken de adelaar eesti as vanapere tee 14 -
ketosol-100
interchemie werken de adelaar eesti as vanapere tee 14 -
zykalor 10 mg tablete
medochemie ltd. - aripiprazol - tableta - aripiprazol 10 mg / 1 tableta - aripiprazol